Director Scott Hill Acquires 40,000 Shares of Cardlytics Inc (CDLX)

Article's Main Image

On August 12, 2024, Scott Hill, Director at Cardlytics Inc (CDLX, Financial), purchased 40,000 shares of the company, as reported in a recent SEC Filing. This transaction increased the insider's total holdings to 40,000 shares.

Cardlytics Inc operates a platform inside banking channels that presents marketing and rewards programs. The company collaborates with financial institutions to run bank rewards programs that promote customer loyalty and deepen banking relationships.

The purchase occurred at a stock price of $3.58, valuing the transaction at approximately $143,200. Following this transaction, the market cap of Cardlytics Inc stands at $175.437 million.

1823185568432025600.png

Over the past year, there have been 7 insider buys and 17 insider sells at Cardlytics Inc. The insider's recent acquisition contrasts with the broader trend of more frequent insider sales over buys.

Regarding valuation, Cardlytics Inc's shares are currently trading significantly below the GF Value of $12.60, with a price-to-GF-Value ratio of 0.28. This valuation suggests that the stock might be a Possible Value Trap, Think Twice before investing.

1823185624673447936.png

The GF Value is calculated considering historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.

This insider purchase could signal a belief in the company's potential value or a strategic move to increase ownership, aligning more closely with company outcomes. Investors should monitor insider transactions as part of their research, alongside comprehensive analysis of the company's fundamentals and market conditions.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.